Damien Alan Perriman
CIK: 0002096714
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
EXOZYMES INC.
Discretionary Trading P&L
Holdings
Transaction History (5 total)
- Oct 12, 2026EXOZ
EXOZYMES INC.
Sale(S)Direct3.7K shares at avg. $5.21$19K - Oct 9, 2026EXOZ
EXOZYMES INC.
Exercise(M)Direct3.9K shares- - Aug 19, 2026EXOZ
EXOZYMES INC.
Exercise(M)Direct19.6K shares- - Apr 1, 2026EXOZ
EXOZYMES INC.
Award(A)Direct62.8K shares- - Apr 1, 2026EXOZ
EXOZYMES INC.
Award(A)Direct8.9K shares at avg. $8.44$75K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Oct 12, 2026 | EXOZ EXOZYMES INC. | Sale(S) | 3,729 | $5.21 | $19,427 | Direct |
| Oct 9, 2026 | EXOZ EXOZYMES INC. | Exercise(M) | 3,922 | - | $0 | Direct |
| Aug 19, 2026 | EXOZ EXOZYMES INC. | Exercise(M) | 19,612 | - | $0 | Direct |
| Apr 1, 2026 | EXOZ EXOZYMES INC. | Award(A) | 62,759 | - | $0 | Direct |
| Apr 1, 2026 | EXOZ EXOZYMES INC. | Award(A) | 8,887 | $8.44 | $75,006 | Direct |
1-5 of 5 transactions
About Perriman Damien Alan
Perriman Damien Alan (SEC CIK 0002096714) files insider reports with the SEC as Chief Commercial Officer of EXOZYMES INC. (EXOZ).
Signal8 holds 5 ownership filings by Perriman Damien Alan (1 Form 3, 4 Form 4), filed between Apr 8, 2026 and Oct 26, 2026. Those filings report 5 transactions, from Apr 1, 2026 to Oct 12, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Perriman Damien Alan's filings is in MONROVIA, CA.
Recent filings by Perriman Damien Alan
Other insiders filing for EXOZYMES INC. (EXOZ)
- Korman Tyler Paz, Chief Scientific Officer
- Rayo Edgardo Javier, Director
- MARLETT CHRISTOPHER A, Director
- Lalonde James Joseph, Director
- DIGIANDOMENICO ANTHONY, Director
- Bowie James Ulrich, Director